$PLRX

$0.85 -$0.01 (1.6%) Close

$PLRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$PLRX Management Team

Mr. Christopher Keenan

Vice President - Investor Relations and Corporate Communications

Age -

Compensation -

Sex Male

Dr. Bernard Coulie

President

Chief Executive Officer

Director

Age 59

Compensation $6.615M USD

Sex Male

Dr. Keith Cummings

Chief Financial Officer

Age 48

Compensation $3.100M USD

Sex Male

Ms. Lily Cheung

Chief Human Resources Officer

Age 52

Compensation -

Sex Female

Dr. Hoyoung Huh

Non-Executive Chairman of the Board

Lead Independent Director

Age 55

Compensation $304.7K USD

Sex Male

Dr. Delphine Imbert

Chief Technical Officer

Age -

Compensation -

Sex Female

Ms. Minnie Kuo

Chief Operating Officer

Age 45

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Christopher Keenan Vice President - Investor Relations and Corporate Communications	-	-	Male
Dr. Bernard Coulie President Chief Executive Officer Director	59	$6.615M USD	Male
Dr. Keith Cummings Chief Financial Officer	48	$3.100M USD	Male
Ms. Lily Cheung Chief Human Resources Officer	52	-	Female
Dr. Hoyoung Huh Non-Executive Chairman of the Board Lead Independent Director	55	$304.7K USD	Male
Dr. Delphine Imbert Chief Technical Officer	-	-	Female
Ms. Minnie Kuo Chief Operating Officer	45	-	Female

Board of Directors

From the proxy statement filed Apr 22, 2026

Directors

serving now

Independent

9 of 10

stated in the proxy

Average tenure

6.1 years

from year joined

CEO also chairs the board

Hoyoung Huh

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Bernard Coulie CEO	60	2016 10 years	Not independent	None stated	Septerna, Inc.	Paid as CEO
Gayle Crowell	75	2019 7 years	Independent	Audit Committee	None stated	$95,100
Steve Krognes	57	2024 2 years	Independent	None stated	Denali Therapeutics	$95,100
Hoyoung Huh Board chair	56	2017 9 years	Independent	Compensation Committee	None stated	Not stated
Darren Cline	61	2023 3 years	Independent	None stated	Pyxis Oncology, Inc.	$90,100
John Curnutte	74	2017 9 years	Independent	Research and Development Committee	None stated	Not stated
Thomas McCourt	68	2023 3 years	Independent	Compensation Committee Research and Development Committee	None stated	$90,100
Suzanne Bruhn Leaving at the meeting	Not stated	Not stated	Independent	Compensation Committee Nominating and Corporate Governance Committee	None stated	Not stated
David Pyott Leaving at the meeting	Not stated	Not stated	Independent	Audit Committee Nominating and Corporate Governance Committee	None stated	$90,100
Katharine Knobil Leaving at the meeting	Not stated	Not stated	Independent	Nominating and Corporate Governance Committee	None stated	$95,100

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 22, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$PLRX Management Team

Mr. Christopher Keenan

Dr. Bernard Coulie

Dr. Keith Cummings

Ms. Lily Cheung

Dr. Hoyoung Huh

Dr. Delphine Imbert

Ms. Minnie Kuo

Board of Directors

Related-party transactions

No related-party transactions disclosed